Provided by Tiger Trade Technology Pte. Ltd.

Capital Research Global Investors

2,910.58
+31.521.09%
Number of Gainers:62
Number of Losers:33
Number of Flat:- -
PE:- -
High:2,924.13
Open:2,879.17
Low:2,879.17
Close:2,879.06
Volume:634.62M
Turnover:132.66B
Market Cap:33.29T
Float Cap:31.66T

Loading ...

Broadcom CEO Hock Tan Speaks at Goldman Sachs Communacopia + Technology Conference 2026

Reuters
·
Sep 09

AMD @ Citi Global TMT Conference. Key Takeaways & Full Transcript

Smartkarma
·
Sep 09

Wall Street Stumbles Again as Rising Crude Prices Fan Inflation Fears

Deep News
·
Sep 09

Zimmer Biomet Holdings Reiterates 2026 Outlook Amid Leadership Changes

MT Newswires Live
·
Sep 09

PayPal Pres., Checkout Sol. & PayPal Frank Keller Disposes of 4,612 Common Shares Worth $256,140.74

Reuters
·
Sep 09

Thermo Fisher upgraded to Buy from Neutral at UBS

TIPRANKS
·
Sep 09

Money Quote: a Bad Day for Amgen Stock

Dow Jones
·
Sep 09

Freeport Indonesia Extends $1.75 Billion Revolving Credit Facility Maturity to September 2031

Reuters
·
Sep 09

MGM Resorts International Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Insulet Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Align Technology Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Hormel Foods Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Hasbro Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

APA Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 09

Darden Restaurants Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Carnival Corp. Ltd. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Autodesk Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Vistra Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 09

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Sep 09